Insight

Aurélien Marabelle: Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology

Aurélien Marabelle/edimark.fr

Dec 15, 2024, 01:24

Aurélien Marabelle: Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology

Aurélien Marabelle, Medical Oncologist at Gustave Roussy and Professor of Clinical Immunology at Paris-Saclay University, shared a recent article on LinkedIn:

“Subtle differences in antibody engineering can make big impacts on treatment efficacy and patient safety.

Check out our latest review on Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology if you want to learn more.”

Title: Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology

Authors: Romane Martineau, Sandrine Susini and Aurelien Marabelle

Aurélien Marabelle

For more updates, follow OncoDaily.

Antibodies in Oncology antibody engineering Aurélien Marabelle cancer Fc Effector Function OncoDaily Oncology patient safety Romane Martineau Sandrine Susini

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Vincent Rajkumar: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma

"The Doctor Who Always Has Candies in His Pocket": A Conversation with Professor Guangchao Zhang, Pioneer of Pediatric Surgical Oncology in China

Special Coverage